Secondary Logo

Journal Logo

You can read the full text of this article if you:

Access through Ovid
Clinical Science

Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor–Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)

Shaffer, Douglas MDa; Kumwenda, Johnstone MBChB, MSc, FRCPb; Chen, Huichao PhDc; Akelo, Victor MBChB, MPHd; Angira, Francis ADPHd; Kosgei, Josphat MBChBe; Tonui, Ronald MBChBf; Ssali, Francis MBChBg; McKhann, Ashley MSc; Hogg, Evelyn BAh; Stewart, V. Ann PhDi; Murphy, Sean C. MD, PhDj; Coombs, Robert MD, PhDk,l; Schooley, Robert MDm;  the A5297 Team

Author Information
JAIDS Journal of Acquired Immune Deficiency Syndromes: February 1, 2022 - Volume 89 - Issue 2 - p 178-182
doi: 10.1097/QAI.0000000000002839
  • Buy

Abstract

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.